Sangamo Therapeutics, Inc.
Status: Publicly traded
Direct answer
Sangamo Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SGMO.
Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company focused on transforming patient lives through the development of genomic medicines. The company leverages advanced platform technologies including gene therapy, cell therapy, genome editing, and genome regulation to achieve its objectives. A cornerstone of Sangamo's approach is its proprietary zinc finger protein (ZFP) technology platform. This...
Can you invest in Sangamo Therapeutics, Inc.?
Yes. Sangamo Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SGMO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sangamo Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.